Bio-Techne Corp. buy Citigroup Inc.
Start price
04.02.26
/
50%
€58.50
Target price
04.02.27
-
Performance (%)
-18.87%
Price
10.04.26
€47.38
Summary
This prediction is currently active. The price of Bio-Techne Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.87%. Dividends of €0.080 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | 3.000% | 3.000% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for TECH provided by MarketBeat